HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David R Cassatt Selected Research

N-(2-mercaptoethyl)-1,3-diaminopropane

3/2005Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure.
12/2003Effects of dose and schedule on the efficacy of ethyol: preclinical studies.
12/2002Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David R Cassatt Research Topics

Disease

5Mucositis
03/2005 - 01/2002
4Radiation Injuries (Radiation Sickness)
01/2021 - 10/2008
4Neoplasms (Cancer)
10/2008 - 12/2002
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2004 - 01/2002
3Xerostomia
01/2004 - 01/2002
2Acute Radiation Syndrome
10/2021 - 07/2011
2Wounds and Injuries (Trauma)
10/2021 - 01/2021
1Inflammation (Inflammations)
01/2021
1COVID-19
01/2021
1Stomatitis
03/2005

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
10/2021 - 01/2002
6Amifostine (Ethyol)FDA LinkGeneric
03/2005 - 01/2002
3N-(2-mercaptoethyl)-1,3-diaminopropaneIBA
03/2005 - 12/2002
2Biological ProductsIBA
01/2021 - 12/2018
1Biomarkers (Surrogate Marker)IBA
01/2021
1Radioisotopes (Radionuclides)IBA
10/2008
1Radiation-Protective Agents (Radiation Protectants)IBA
01/2002

Therapy/Procedure

4Radiotherapy
01/2021 - 01/2002
2Intravenous Administration
11/2003 - 12/2002
1Aftercare (After-Treatment)
01/2002